AIMS: There is an urgent need for positron emission tomography (PET) imaging of the nicotinic acetylcholine receptors (nAChR) to study the role of the nicotinic system in Alzheimer's and Parkinson's diseases, schizophrenia, drug dependence and many other disorders. Greater understanding of the underlying mechanisms of the nicotinic system could direct the development of medications to treat these disorders. Central nAChRs also contribute to a variety of brain functions, including cognition, behavior and memory. MAIN METHODS: Currently, only two radiotracers, (S)-3-(azetidin-2-ylmethoxy)-2-[(18)F]fluoropyridine (2-[(18)F]FA) and (S)-5-(azetidin-2-ylmethoxy)-2-[(18)F]fluoropyridine (6-[(18)F]FA), are available for studying nAChRs in human brain using PET. However, the "slow" brain kinetics of these radiotracers hamper mathematical modeling and reliable measurement of kinetic parameters since it takes 4-7 h of PET scanning for the tracers to reach steady state. The imaging drawbacks of the presently available nAChR radioligands have initiated the development of radioligands with faster brain kinetics by several research groups. KEY FINDINGS: This minireview attempts to survey the important achievements of several research groups in the discovery of PET nicotinic radioligands reached recently. Specifically, this article reviews papers published from 2006 through 2008 describing the development of fifteen new nAChR (11)C-and (18)F-ligands that show improved imaging properties over 2-[(18)F]FA. SIGNIFICANCE: The continuous efforts of radiomedicinal chemists led to the development of several interesting PET radioligands for imaging of nAChR including [(18)F]AZAN, a potentially superior alternative to 2-[(18)F]FA. Copyright 2009 Elsevier Inc. All rights reserved.
AIMS: There is an urgent need for positron emission tomography (PET) imaging of the nicotinic acetylcholine receptors (nAChR) to study the role of the nicotinic system in Alzheimer's and Parkinson's diseases, schizophrenia, drug dependence and many other disorders. Greater understanding of the underlying mechanisms of the nicotinic system could direct the development of medications to treat these disorders. Central nAChRs also contribute to a variety of brain functions, including cognition, behavior and memory. MAIN METHODS: Currently, only two radiotracers, (S)-3-(azetidin-2-ylmethoxy)-2-[(18)F]fluoropyridine (2-[(18)F]FA) and (S)-5-(azetidin-2-ylmethoxy)-2-[(18)F]fluoropyridine (6-[(18)F]FA), are available for studying nAChRs in human brain using PET. However, the "slow" brain kinetics of these radiotracers hamper mathematical modeling and reliable measurement of kinetic parameters since it takes 4-7 h of PET scanning for the tracers to reach steady state. The imaging drawbacks of the presently available nAChR radioligands have initiated the development of radioligands with faster brain kinetics by several research groups. KEY FINDINGS: This minireview attempts to survey the important achievements of several research groups in the discovery of PET nicotinic radioligands reached recently. Specifically, this article reviews papers published from 2006 through 2008 describing the development of fifteen new nAChR (11)C-and (18)F-ligands that show improved imaging properties over 2-[(18)F]FA. SIGNIFICANCE: The continuous efforts of radiomedicinal chemists led to the development of several interesting PET radioligands for imaging of nAChR including [(18)F]AZAN, a potentially superior alternative to 2-[(18)F]FA. Copyright 2009 Elsevier Inc. All rights reserved.
Authors: W Sihver; K J Fasth; M Ogren; H Lundqvist; M Bergström; Y Watanabe; B Långström; A Nordberg Journal: Nucl Med Biol Date: 1999-08 Impact factor: 2.408
Authors: A G Horti; S I Chefer; A G Mukhin; A O Koren; D Gündisch; J M Links; V Kurian; R F Dannals; E D London Journal: Life Sci Date: 2000-06-16 Impact factor: 5.037
Authors: U Scheffel; A G Horti; A O Koren; H T Ravert; J P Banta; P A Finley; E D London; R F Dannals Journal: Nucl Med Biol Date: 2000-01 Impact factor: 2.408
Authors: Yongjun Gao; Andrew G Horti; Hiroto Kuwabara; Hayden T Ravert; Daniel P Holt; Anil Kumar; Mohab Alexander; Dean F Wong; Robert F Dannals Journal: Bioorg Med Chem Lett Date: 2008-10-07 Impact factor: 2.823
Authors: James Robert Brašić; Nicola Cascella; Anil Kumar; Yun Zhou; John Hilton; Vanessa Raymont; Andrew Crabb; Maria Rita Guevara; Andrew G Horti; Dean Foster Wong Journal: Synapse Date: 2011-12-29 Impact factor: 2.562
Authors: A T Hillmer; D W Wooten; J M Moirano; M Slesarev; T E Barnhart; J W Engle; R J Nickles; D Murali; M L Schneider; J Mukherjee; B T Christian Journal: Synapse Date: 2011-08-31 Impact factor: 2.562
Authors: Andrew G Horti; Hayden T Ravert; Yongjun Gao; Daniel P Holt; William H Bunnelle; Michael R Schrimpf; Tao Li; Jianguo Ji; Heather Valentine; Ursula Scheffel; Hiroto Kuwabara; Dean F Wong; Robert F Dannals Journal: Nucl Med Biol Date: 2013-01-05 Impact factor: 2.408
Authors: Kasia M Bieszczad; Ritu Kant; Cristian C Constantinescu; Suresh K Pandey; Hideki D Kawai; Raju Metherate; Norman M Weinberger; Jogeshwar Mukherjee Journal: Synapse Date: 2012-02-15 Impact factor: 2.562
Authors: Yongjun Gao; Hayden T Ravert; Heather Valentine; Ursula Scheffel; Paige Finley; Dean F Wong; Robert F Dannals; Andrew G Horti Journal: Bioorg Med Chem Date: 2012-05-04 Impact factor: 3.641